It's properly understood that IL-two is often a pleiotropic cytokine positioned with the crossroads of T mobile activation and regulation. As a result, it is very important to engineer an IL-two molecule that may be biased in direction of effector cells bearing the intermediate affinity receptor, including naïve and memory CD8+ T cells and NK cell